Phase II Trial of Plinabulin in Combination with Nivolumab and Ipilimumab in Patients with Recurrent Small Cell Lung Cancer (SCLC): Big Ten Cancer Research Consortium (BTCRC-LUN17-127) study
Ipilimumab;Nivolumab;Plinabulin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase II Trial of Plinabulin in Combination with Nivolumab and Ipilimumab in Patients with Recurrent Small Cell Lung Cancer (SCLC): Big Ten Cancer Research Consortium (BTCRC-LUN17-127) study ### Output: Ipilimumab;Nivolumab;Plinabulin